In a perfect world, the location would never factor in a patient’s access to specialized cancer care. The reality is that in a state as vast as Texas, patients often travel long distances for consultations and treatment. Traveling for consideration can be exhausting for patients and timely and costly for families and caregivers. That’s why telemedicine can be a viable and beneficial option, when appropriate, for the patient and physician.

In recent years we’ve seen extraordinary medical advancements and technological innovations in oncology and the healthcare industry. While telemedicine has existed in various forms for years, its use is becoming more common in oncology care. So, what is it, and how might you or a loved one benefit from it?

Telemedicine enables physicians to connect directly with patients who need highly specialized care, even if they live many miles away from the physicians’ offices and clinics. We do this through a range of technologies, including video conferencing solutions that allow patients to see and speak directly with the physician and enable the medical team to share files, documents, and images on the screen.

telemedicne
telemedicne
With telemedicine, patients have extensive and diverse expertise with more treatment options. At the same time, saving time and expense and limiting travel to a distant treatment facility.

Physicians within a healthcare network can access patient records and share files through encrypted, HIPPA-compliant technology to discuss test results, treatment options, and more.

Telemedicine does not eliminate patients’ need to travel for certain aspects of treatment and in-person doctor visits. But the robust communications technology effectively extends healthcare providers’ reach by allowing some consultations and follow-ups to take place remotely. This is vitally important in many Texas areas, where access to specialty healthcare is limited or even non-existent.

For example, suppose a patient in Houston, Austin, or El Paso, has been identified as a potential candidate for highly precise proton therapy. In that case, the Texas Center for Proton Therapy team in Irving, Texas, can use telemedicine to conduct a preliminary consultation with the patient to determine if the treatment is appropriate for them. The patient may only have to travel for treatment because they may conduct consultations and follow-ups via telemedicine. The same is true of treatment for patients of Texas Oncology’s Austin Brain Tumor Center, helping make world-renowned brain cancer expertise available to patients regardless of where they live.

The patient visits their local physician’s office for the appointment, where the appropriate specialist is added remotely via telemedicine technology. Specialties available also include:

  • Blood and marrow transplant.
  • CAR-T therapy.
  • Pediatric hematology or oncology.
  • Advance care planning.
Texas Oncology network

Within our Texas Oncology network, telemedicine makes it possible for patients to connect with more than 420 physicians by allowing some consultations and follow-up to take place remotely. Consultations can include voice, videoconferencing, sharing and reviewing scans and images, coordination of local supportive care, symptom management – or any combination of those services as clinical circumstances require.


Telemedicine is making it possible to reach more patients and deliver care more efficiently and conveniently, regardless of the patient or physician’s location. The future of cancer care is exciting. I’m proud to work for a network that embraces telemedicine that is effective for patients and doesn’t compromise quality or confidentiality – even when a patient is hundreds of miles away.

By Benjamin West, M.D.

BENJAMIN WEST, M.D.
+ posts

He earned his medical degree in 1989 from the University of Alabama, Birmingham School of Medicine in Birmingham, Alabama. He completed his internship in Internal Medicine at Louisiana State University School of Medicine, New Orleans, Louisiana in 1990 followed by his fellowship in Radiation Oncology in 1993 at Strong Memorial Hospital in Rochester, New York.